Comparative Outcomes of Relapsed Follicular Lymphoma Patients Treated with Novel Agents: A Multi-Center Analysis
Year: 2019
Type: conference-abstract
Source: Blood
Authors: Allison M. Winter, Wei Wei, Emily C. Ayers, Daniel J. Landsburg, Saba Raya, Brad S. Kahl, Andrew Rogers, Kami J. Maddocks, Mohammad Khan, Adam S. Kittai, Alexey Danilov, Chaitra S. Ujjani, Ryan C. Lynch, Loretta J. Nastoupil, Melody R. Becnel, Luke Zurbriggen, Vaishalee P. Kenkre, Sheenu Sheela, Nilanjan Ghosh, Boyu Hu, Deborah M. Stephens, Amy Ayers, Jonathon B. Cohen, Brian T. Hill
Institutions: Cleveland Clinic, Abramson Cancer Center, University of Pennsylvania, Washington University in St. Louis, Ohio State University Hospital, The Ohio State University, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Oregon Health & Science University, OHSU Knight Cancer Institute, University of Washington, Fred Hutch Cancer Center, Seattle Cancer Care Alliance, The University of Texas MD Anderson Cancer Center, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Levine Cancer Institute, Huntsman Cancer Institute, Emory University, Winship Cancer Institute
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2983286405
